Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Titel:
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Auteur:
Arribas, José R Girard, Pierre-Marie Landman, Roland Pich, Judit Mallolas, Josep Martínez-Rebollar, María Zamora, Francisco X Estrada, Vicente Crespo, Manuel Podzamczer, Daniel Portilla, Joaquín Dronda, Fernando Iribarren, José A Domingo, Pere Pulido, Federico Montero, Marta Knobel, Hernando Cabié, André Weiss, Laurence Gatell, José M